Trial Profile
Immunogenicity and reactogenicity of an inactivated varicella zoster virus vaccine in patients with autoimmune disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2014
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Chickenpox; Varicella zoster virus infections
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 04 Jan 2014 Results published in Arthritis and Rheumatism.
- 04 Jan 2014 New trial record